Press releases

Acquisition brings Boston Scientific the first fully repositionable device for percutaneous aortic valve replacement to treat severe aortic stenosis

Company prepays $600 million of debt

Company will participate in the conference on January 11, 2011. A live webcast and replay will be available.

Distinguished leader brings broad range of expertise in science, technology, business, education and government

Patients experienced a 50 percent relative reduction in risk of death compared to in-clinic follow-up